Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden

Pincez, T; Fernandes, H; Leblanc, T; Michel, G; Barlogis, V; Bertrand, Y; Neven, B; Abou Chahla, W; Pasquet, M; Guitton, C; Marie-Cardine, A; Pellier, I; Armari-Alla, C; Benadiba, J; Blouin, P; Jeziorski, E; Millot, F; Paillard, C; Thomas, C; Cheikh, N; Bayart, S; Fouyssac, F; Piguet, C; Deparis, M; Briandet, C; Dore, E; Picard, C; Rieux-Laucat, F; Landman-Parker, J; Leverger, G; Aladjidi, N

Aladjidi, N (通讯作者)，Ctr Reference Natl Cytopenies Autoimmunes Enfant, Bordeaux, France.;Aladjidi, N (通讯作者)，INSERM, Ctr Invest Clin CIC 1401, Pediat Oncol Hematol Unit, Univ Hosp,Plurithemat CIC CICP, Bordeaux, France.

HAEMATOLOGICA, 2022; 107 (2): 457

Abstract

Pediatric-onset Evans syndrome (pES) is defined by both immune thrombocytopenic purpura (ITP) and autoimmune hemolytic anemia (AIHA) before the age of......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索